Streetbeat News

Stock Prices

AIM

AIM ImmunoTech has announced new pre-clinical data indicating that its drug Ampligen, when used as part of a combination therapy, slows melanoma tumor growth and improves survival in a mouse model.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:50 pm

HZO

Island Capital Group has raised concerns about MarineMax's operating strategy, highlighting excessive senior management compensation exceeding $10 million per year. This has cost shareholders $50M-$100M in value, while the company's EBITDA run rate has dropped by over $100M and the stock price has fallen by more than 40% in the past three years.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:47 pm

PII

Polaris Inc. (NYSE:PII) reported disappointing Q2 results, missing both earnings and sales estimates. The company also significantly cut its 2024 guidance, leading to a 4.8% drop in its stock price. Analysts from BMO Capital and B of A Securities lowered their price targets for Polaris.

Portfolio Pulse from Avi Kapoor

July 24, 2024 | 12:43 pm

BOOT

TFC

ULTA

Top Wall Street analysts have downgraded several major companies, including General Motors, Procter & Gamble, Boot Barn Holdings, Ulta Beauty, and Truist Financial Corporation. Despite some price target adjustments, the downgrades have led to varying impacts on their stock prices.

Portfolio Pulse from Avi Kapoor

July 24, 2024 | 12:38 pm

KOPN

Kopin Corporation (NASDAQ:KOPN) has announced reaching the alpha testing stage for its NeuralDisplay™ platform software, marking a significant milestone in its development.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:35 pm

NMHI

Nature's Miracle Holdings Inc. (NASDAQ:NMHI) has received a $2.4 million purchase order for its Efinity LED grow lights from a top indoor grower in California. The order will be paid starting October 1, 2024, with delivery in late November 2024, boosting the company's Q4 2024 revenue by $2.4 million.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:34 pm

GOOG

GOOGL

INUV

Inuvo provides insights on Google's decision to deprecate third-party cookies in Chrome and highlights the impact on its generative AI advertiser solution for brands and agencies.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:33 pm

SONN

Sonnet BioTherapeutics reported positive data from its Phase 1b/2a clinical trial of SON-080 for chemotherapy-induced peripheral neuropathy, showing good tolerance and potential symptom improvement. The company plans to seek a partnership for a Phase 2 trial in diabetic peripheral neuropathy.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:33 pm

ACHR

CHPT

ENVX

ICLN

JOBY

PLUG

QCLN

As Q2 earnings season approaches, clean tech stocks like Enovix Corp (NASDAQ:ENVX) and ChargePoint Holdings Inc (NYSE:CHPT) are in focus. Despite recent gains, the sector remains volatile. Analyst Bill Peterson highlights cautious investor sentiment and elevated short interest. Enovix has announced new commercial agreements and plans to scale production, leading to a raised price target. ChargePoint is expected to see sequential improvement but faces mixed demand. Archer Aviation Inc (NYSE:ACHR) and Joby Aviation Inc (NYSE:JOBY) have surged but may not align with fundamentals. Plug Power Inc (NASDAQ:PLUG) faces policy uncertainty affecting growth. The sector faces political and economic risks, with upcoming earnings likely to address these issues.

Portfolio Pulse from Surbhi Jain

July 24, 2024 | 12:33 pm

BCLI

BrainStorm Cell Therapeutics provided updates on its NurOwn stem cell therapy for ALS, including resolving CMC FDA questions, beginning the PIIIb rollout, raising $4M, and setting up a commercialization team. Despite a ~5% value range reduction due to dilution, the investment hypothesis remains strong with potential >10x returns. The company is also exploring non-dilutive grant funds.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 12:33 pm